Market Access News | pharmaphorum

News

Dose-at-home Leqembi for Alzheimer's cleared in US

Eisai and Biogen get FDA approval for subcutaneous Leqembi. Will it help stave off growing competition from Lilly's Kisunla in Alzheimer's treatment?

News

Jim O’Neill, Deputy Secretary, Department of Health and Human Services

Trump appoints HHS deputy O'Neill to lead CDC

The current director of the CDC is challenging her dismissal, but that has not stopped the White House from appointing a replacement.

News

UK adds chickenpox to childhood vaccination schedule

The UK will offer free vaccination against chickenpox to young children from the start of 2026, in the hope of eliminating cases in a couple of years.

News

Downward market trajectory in black bar chart

Outlook blindsided as FDA blocks wet AMD drug once again

Shares in Outlook Therapeutics lost more than half their value after the FDA turned down the company's marketing application for its wet AMD therapy.

News

Lilly pauses Mounjaro orders in UK ahead of price hike

Lilly has paused shipments of weight loss therapy Mounjaro to the UK to prevent stockpiling ahead of a price rise, but patients report shortages.

News

Dr Susan Monarez being sworn in as CDC director in July.

CDC director refuses to step down after being fired

An attempt by the HHS to oust Susan Monarez as director of the CDC has run into a snag – she is refusing to step down.

Dose-at-home Leqembi for Alzheimer's cleared in US

Trump appoints HHS deputy O'Neill to lead CDC

UK adds chickenpox to childhood vaccination schedule

Outlook blindsided as FDA blocks wet AMD drug once again

Lilly pauses Mounjaro orders in UK ahead of price hike

CDC director refuses to step down after being fired

Lilly UK recruits ex-England cricketer as obesity champion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks